MicroGen DX provides physicians and their patients with the most advanced molecular based microbial testing available. Through the utilization of Next Generation DNA Sequencing (NGS), MicroGen DX identifies causative microbes within patient samples and matches DNA sequence codes of 25,000 microbial species with 99.9% accuracy. This technology provides physicians with the precise information needed to make confident treatment decisions based on solid DNA evidence. This knowledge ensures targeted antibiotic selection leading to better antibiotic stewardship and overall health of patients their their treatment regiments.